3Suppliers
6Customers
2Debt Items
20Related Chains

GridAI Technologies Corp. Suppliers

TickerNameConfidenceEvidence
1396974-BC-LTD 1396974-BC-LTD 92% GridAI Technologies Corp. entered into a Revolving Loan Agreement dated January 27, 2025 (the “Revolving Loan Agreement”), with 1396974 BC Ltd. (the “Lender”) pursuant to which the Lender agreed to m…
SNYNF Sanofi 72% s and potential disruption in the operations and business of third-party vendors, contract research organizations (“CROs”), contract development and manufacturing organizations (“CDMOs”), other servi…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from GRDX graph: s and potential disruption in the operations and business of third-party vendors, contract research organizations (“…

GridAI Technologies Corp. Customers

TickerNameConfidenceEvidence
ASYMCHEM-LIFE-SCIENCE-CO-LTD ASYMCHEM-LIFE-SCIENCE-CO-LTD 85% e API is derived is kept at a storage facility maintained by Charles River Laboratories Inc. Adrulipase drug substance and drug product are currently manufactured at a contract facility located in Ti…
GOVERNMENT-REGULATION-GRID-AI-CORP GOVERNMENT-REGULATION-GRID-AI-CORP 85% r plants, and wholesale market participation. Changes in laws, regulations, market rules, or regulatory interpretations could impact the ability of customers to deploy Grid AI Corp.’ solutions, parti…
GRIS-AI-CORP GRIS-AI-CORP 85% gh direct sales and strategic partnerships with energy developers, system integrators, engineering firms, and other industry participants. Gris Ai Corp. has commenced early-stage development activiti…
MAJOR-CUSTOMERS-GRID-AI-CORP MAJOR-CUSTOMERS-GRID-AI-CORP 85% ill depend on the progress of customer projects, including construction and operational readiness milestones, as well as the availability of customer funding. -3- Table of Contents Sources and Availa…
SNYNF Sanofi 72% parties as set forth in the Rescission Agreement to consummate the transactions contemplated by this Agreement, (ii) the Shareholders shall have delivered a mutually satisfactory voting agreement agr…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from GRDX graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from GRDX graph: Reciprocal relationship from SNYN…

GridAI Technologies Corp. Debt Obligations

InstrumentDescriptionConfidenceEvidence
GRDX-DEBT-9874 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
GRDX-DEBT-9873 Warrants outstanding: 5659110 90% xbrl warrant detail from xbrl 2025-12-31.

GridAI Technologies Corp. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for GridAI Technologies Corp..

GridAI Technologies Corp. Ownership

HolderNameConfidenceEvidence
GRDX-OWNER-RENAISSANCE-TECHNOLOGIES-LLC RENAISSANCE TECHNOLOGIES LLC 90% 13F overlay lists RENAISSANCE TECHNOLOGIES LLC as top holder; 14 tracked holders.

GridAI Technologies Corp. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2